首页> 美国卫生研究院文献>International Journal of Endocrinology >Coronary Heart Disease in Postmenopausal Women with Type II Diabetes Mellitus and the Impact of Estrogen Replacement Therapy: A Narrative Review
【2h】

Coronary Heart Disease in Postmenopausal Women with Type II Diabetes Mellitus and the Impact of Estrogen Replacement Therapy: A Narrative Review

机译:绝经后II型糖尿病女性的冠心病和雌激素替代疗法的影响:叙事回顾。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Coronary heart disease is the main cause of death in postmenopausal women (PMW); moreover its mortality exceeds those for breast cancer in women at all ages. Type II diabetes mellitus is a major cardiovascular risk factor and there is some evidence that the risk conferred by diabetes is greater in women than in men. It was established that the deficiency of endogenous estrogens promotes the atherosclerosis process. However, the impact of estrogen replacement therapy (ERT) on cardiovascular prevention remains controversial. Some authors strongly recommend it, whereas others revealed a concerning trend toward harm. This review tries to underlines the different components of cardiovascular risk in diabetic PMW and to define the place of ERT.
机译:冠心病是绝经后妇女(PMW)的主要死亡原因;而且,其死亡率超过所有年龄段的妇女的乳腺癌死亡率。 II型糖尿病是心血管的主要危险因素,并且有一些证据表明,女性患糖尿病的风险比男性高。已经确定,内源性雌激素的缺乏促进了动脉粥样硬化过程。然而,雌激素替代疗法(ERT)对心血管预防的影响仍存在争议。一些作者强烈建议这样做,而另一些人则显示出令人担忧的危害趋势。这篇综述试图强调糖尿病性PMW中心血管疾病风险的不同组成部分,并确定ERT的位置。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号